Follicular Lymphoma Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is a Follicular Lymphoma?
Follicular lymphoma is a type of B-cell non-Hodgkin lymphoma that develops from abnormal B lymphocytes, a type of white blood cell involved in the immune system. It is generally considered an indolent, or slow-growing, lymphoma, although its behaviour can vary between individuals. Follicular lymphoma commonly affects lymph nodes but can also involve the bone marrow, spleen, and other tissues.
What is the Importance of Timely Treatment?
Timely diagnosis and appropriate management can help determine the extent and biological characteristics of follicular lymphoma and guide treatment decisions. Because many cases grow slowly, immediate treatment is not always necessary. Some patients with asymptomatic, low-burden disease may be monitored through active surveillance, or watchful waiting.
What are the Common Symptoms of Follicular Lymphoma?
- Painless swelling of lymph nodes in the neck, armpit, or groin
- Persistent fatigue or weakness
- Unexplained weight loss
- Fever without an obvious infection
- Drenching night sweats
- Abdominal discomfort or fullness due to an enlarged spleen or lymph nodes
- Recurrent infections in some patients
- Shortness of breath or other symptoms when enlarged lymph nodes affect nearby structures
Causes and Risk Factors of Follicular Lymphoma
Causes
- The exact cause of follicular lymphoma is not fully understood. It develops when genetic changes in B lymphocytes cause them to grow or survive abnormally.
- A characteristic genetic change involving the BCL2 gene on chromosome 18 is commonly associated with follicular lymphoma, although this change alone does not necessarily cause lymphoma.
Risk Factors
- Increasing age
- Certain abnormalities of the immune system
- Immunosuppressive conditions or treatments
- Some autoimmune diseases
- Certain infections or environmental exposures may be associated with lymphoma risk, although their specific role in follicular lymphoma varies
Latest Research and Technologies in the Treatment of Follicular Lymphoma in Malaysia
- Advances in follicular lymphoma treatment include newer immunotherapies, such as bispecific antibodies and CAR-T cell therapy, for selected patients whose disease has relapsed or not responded to previous treatments. Improved pathological and molecular testing also helps specialists characterise the lymphoma and guide treatment decisions. In Malaysia, access to these newer therapies depends on regulatory approval, hospital capabilities and individual eligibility; no recent Malaysia-specific breakthrough was verified
Treatment options for Follicular Lymphoma
Immunotherapy : Anti-CD20 antibodies may be used alone or in combination with other treatments.
Cost Start From 5000Explore Options
Chemoimmunotherapy: Chemotherapy combined with an antibody may be considered for patients who require systemic treatment.
Targeted therapy : Targeted medicines may be considered in selected relapsed or refractory cases.
Cost Start From 4000Explore Options
CAR-T cell therapy : For selected patients with relapsed or refractory follicular lymphoma after previous systemic treatments, CAR-T therapy may be considered at specialised centres.
Cost Start From 250000Explore Options
Stem cell transplantation : Autologous stem cell transplantation may be considered in selected patients with relapsed or refractory disease, although its use depends on the clinical situation and availability of newer therapies.
Cost Start From 16000Explore Options
- Clinical assessment:
- Detailed medical history and physical examination: including assessment of enlarged lymph nodes, spleen, and other symptoms. Blood tests may evaluate blood cell counts, kidney and liver function, and other relevant markers.
- Tissue biopsy: An excisional or core lymph-node biopsy is generally important to confirm the diagnosis and determine the lymphoma subtype and grade. Immunohistochemistry and other pathological tests help identify characteristic markers.
- Bone marrow evaluation: Bone marrow testing may be considered in selected patients depending on the clinical situation and whether the results will influence staging or treatment.
- Imaging Tests:
- PET/CT scan: Helps assess where lymphoma is present in the body, supports staging in appropriate cases, and evaluates treatment response. It may also help identify areas that require further investigation when transformation into a more aggressive lymphoma is suspected.
- CT scan: Can evaluate enlarged lymph nodes and involvement of organs such as the chest, abdomen, and pelvis.
- MRI: May be used when detailed assessment of particular organs or anatomical areas is required.
- Ultrasound: Can help evaluate superficial lymph nodes or abdominal organs in selected cases.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Follicular Lymphoma patients in Malaysia. These services include:
- Physical activity: Gradual activity can help maintain strength and endurance.
- Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
- Nutritional support: Helps maintain adequate calorie and protein intake during treatment.
- Fatigue management: Structured activity, rest, sleep support, and energy conservation strategies can help manage cancer-related fatigue.
- Psychological support: Counselling and supportive-care services may help patients cope with the emotional impact of diagnosis and treatment.
- Treatment for follicular lymphoma depends on the disease stage, symptoms, tumor size, past treatments, and response to therapy. Options include antibody treatments, chemotherapy, immune-modulating drugs, targeted treatments, and other immune-based therapies. Some people can be monitored without treatment, while others need systemic therapy. A blood cancer specialist chooses the treatment based on each person’s needs.
Instantly Connect with our Specialists
Hospitals for Follicular Lymphoma in Malaysia
Parkway Pantai
Kuala Lumpur, Malaysia
Parkway Pantai located in Kuala Lumpur, Malaysia is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Capacity of 335 beds
- 200+ specialist Doctors
- Critical Care Unit
- Neonatal Intensive Care Unit
- Operating Theatre
- International Patient Care Center
- Types of rooms available- Premier Suite, Supreme Suite, Deluxe Single Room, 2-bedded room, 4-bedded room, Deluxe Suite, Premier Single room, and Supreme Single room
Sunway Medical Centre
Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.
Prince Court Medical Centre
Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Follicular Lymphoma Treatment?
- Experienced hematologist-oncologists: Specialists experienced in lymphoma diagnosis, systemic therapy, and long-term disease management.
- Advanced diagnostic facilities: PET/CT, immunohistochemistry, flow cytometry, cytogenetic and molecular testing can support accurate diagnosis and treatment planning.
- Modern treatment options: Eligible patients may have access to immunotherapy, targeted treatments, bispecific antibodies, and cellular therapies at specialised centres.
- Multidisciplinary care: Haematologists, oncologists, pathologists, radiologists, radiation oncologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
- International patient support: Many hospitals offer dedicated international patient services that can help with medical coordination, documentation, accommodation, travel arrangements, and follow-up planning.
Frequently Asked Questions
Reviewer
Dr. Mohit Agarwal
Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026